Find Phentolamine Mesylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

30 RELATED EXCIPIENT COMPANIES

61EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 65-28-1, Phentolamine mesilate, Phentolamine methanesulfonate, Phentolamine (mesylate), Oraverse, Regitine mesylate
Molecular Formula
C18H23N3O4S
Molecular Weight
377.5  g/mol
InChI Key
OGIYDFVHFQEFKQ-UHFFFAOYSA-N
FDA UNII
Y7543E5K9T

Phentolamine Mesylate
A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.
1 2D Structure

Phentolamine Mesylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic acid
2.1.2 InChI
InChI=1S/C17H19N3O.CH4O3S/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15;1-5(2,3)4/h2-8,11,21H,9-10,12H2,1H3,(H,18,19);1H3,(H,2,3,4)
2.1.3 InChI Key
OGIYDFVHFQEFKQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
Y7543E5K9T
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Fentolamin

2. Mesilate, Phentolamine

3. Mesylate, Phentolamine

4. Methanesulfonate, Phentolamine

5. Mono-hydrochloride, Phentolamine

6. Phentolamine

7. Phentolamine Mesilate

8. Phentolamine Methanesulfonate

9. Phentolamine Mono Hydrochloride

10. Phentolamine Mono-hydrochloride

11. Regitine

12. Regityn

13. Rogitine

14. Z-max

2.3.2 Depositor-Supplied Synonyms

1. 65-28-1

2. Phentolamine Mesilate

3. Phentolamine Methanesulfonate

4. Phentolamine (mesylate)

5. Oraverse

6. Regitine Mesylate

7. Phentolamine Methanesulfonate Salt

8. Phentolamine Mesylate [usp]

9. Mesylate Phentolamine

10. 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(p-tolyl)amino)phenol Methanesulfonate

11. Nv-101

12. Mls000069487

13. Y7543e5k9t

14. M-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)phenol Monomethanesulfonate (salt)

15. Phenol, 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(4-methylphenyl)amino)-, Monomethanesulfonate (salt)

16. Phenol,3-[[(4,5-dihydro-1h-imidazol-2-yl)methyl](4-methylphenyl)amino]-,monomethanesulfonate (salt)

17. Smr000059054

18. 3-[n-(4,5-dihydro-1h-imidazol-2-ylmethyl)-4-methylanilino]phenol;methanesulfonic Acid

19. Phentolamine Mesylate (usp)

20. Vasomax

21. Regitin Methanesulphonate

22. Regitine Methanesulfonate

23. Phenol, M-[n-(2-imidazolin-2-ylmethyl)-p-toluidino]-, Methanesulfonate (1:1)

24. Phentolamine Methanesulphonate

25. Ccris 9022

26. Phentolamine Mesilate [inn:ban]

27. Einecs 200-604-6

28. Vasofem

29. Unii-y7543e5k9t

30. Regitin Mesylate

31. Sr-01000000055

32. Regitine (tn)

33. Z-max

34. Mfcd00134201

35. Opera_id_1599

36. Lopac-p-7561

37. Phentolamine Meslate,(s)

38. Schembl40852

39. Mls001076484

40. Phentolamine, Methyl Sulfonate

41. Regid_for_cid_91430

42. Chembl1200873

43. Hy-b0362a

44. Dtxsid60215315

45. Phentolamine Mesilate (jan/inn)

46. Hms2233a24

47. Hms3263e05

48. Hms3373d03

49. Hms3655b13

50. Hms3884a22

51. Phentolamine Mesilate [jan]

52. Bcp09845

53. Tox21_500982

54. Phentolamine Mesylate [vandf]

55. S2038

56. 3-fluoropyridine-4-boronicacidhydrate

57. Phentolamine Mesilate [mart.]

58. Akos007930193

59. Phentolamine Mesilate [who-dd]

60. Phentolamine Mesylate [usp-rs]

61. Ac-7472

62. Ccg-222286

63. Lp00982

64. 3-[n-(4,5-dihydro-1h-imidazol-2-ylmethyl)-4-methylanilino]phenol; Methanesulfonic Acid

65. Phenol, M-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)-, Monomethanesulfonate (salt)

66. Ncgc00016195-01

67. Ncgc00016195-02

68. Ncgc00094282-01

69. Ncgc00261667-01

70. As-13800

71. Phentolamine Methanesulfonate [mi]

72. Phentolamine Mesylate [orange Book]

73. Phentolamine Mesilate [ep Monograph]

74. Eu-0100982

75. Ft-0603267

76. P1985

77. Phentolamine Mesylate [usp Monograph]

78. Sw196637-3

79. D00509

80. P 7561

81. T72782

82. 134p201

83. A835046

84. Sr-01000000055-3

85. W-104799

86. Q27294332

87. Phentolamine Methanesulfonate Salt, >=98% (tlc), Powder

88. Phentolamine Mesilate, British Pharmacopoeia (bp) Reference Standard

89. 2-[n-(m-hydroxyphenyl)-p-toluidinomethyl]imidazoline Methanesulfonate

90. Phentolamine Mesilate, European Pharmacopoeia (ep) Reference Standard

91. Phentolamine Mesylate, United States Pharmacopeia (usp) Reference Standard

92. 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(p-tolyl)amino)phenolmethanesulfonate

93. 3-[[(4,5-dihydro-1h-imidazol-2-yl)methyl](4-methylphenyl)amino]phenol Methanesulfonate

94. 3-[4,5-dihydro-1h-imidazol-2-ylmethyl-(4-methylphenyl)amino]phenol; Methanesulfonic Acid

95. 3-[n-(4,5-dihydro-1h-imidazol-1-ium-2-ylmethyl)-4-methylanilino]phenol;methanesulfonate

96. M-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)phenol Monomethanesulphonate (salt)

97. Phentolamine Mesilate For System Suitability, European Pharmacopoeia (ep) Reference Standard

98. Phentolamine Mesylate, Pharmaceutical Secondary Standard; Certified Reference Material

99. Phenol, 3-(((4,5-dihydro-1h-imidazol-2-yl)methyl)(4-methylphenyl)amino)-, Monomethanesulphonate (salt)

2.4 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 377.5 g/mol
Molecular Formula C18H23N3O4S
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass377.14092740 g/mol
Monoisotopic Mass377.14092740 g/mol
Topological Polar Surface Area111 Ų
Heavy Atom Count26
Formal Charge0
Complexity456
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NamePhentolamine mesylate
Drug LabelPhentolamine Mesylate for Injection USP, is an antihypertensive, available in vials for intravenous and intramuscular administration. Each vial contains phentolamine mesylate USP, 5 mg and mannitol USP, 25 mg in sterile, lyophilized form.Phentolamine...
Active IngredientPhentolamine mesylate
Dosage FormInjectable
RouteInjection
Strength5mg/vial
Market StatusPrescription
CompanyEurohlth Intl

2 of 4  
Drug NameOraverse
PubMed HealthPhentolamine (Injection)
Drug ClassesAntihypertensive, Diagnostic Agent, Pheochromocytoma, Toxicology-Antidote Agent
Drug LabelPhentolamine mesylate is phenol,3-[[(4,5-dihydro-1 H-imidazol-2-yl)methyl](4-methyl-phenyl)amino]-, methanesulfonate (salt), a non-specific alpha adrenergic blocker.Phentolamine mesylate USP is a white to off-white, odorless crystalline powder with a...
Active IngredientPhentolamine mesylate
Dosage FormInjectable
RouteInjection
Strength0.4mg/1.7ml
Market StatusPrescription
CompanySeptodont Holding

3 of 4  
Drug NamePhentolamine mesylate
Drug LabelPhentolamine Mesylate for Injection USP, is an antihypertensive, available in vials for intravenous and intramuscular administration. Each vial contains phentolamine mesylate USP, 5 mg and mannitol USP, 25 mg in sterile, lyophilized form.Phentolamine...
Active IngredientPhentolamine mesylate
Dosage FormInjectable
RouteInjection
Strength5mg/vial
Market StatusPrescription
CompanyEurohlth Intl

4 of 4  
Drug NameOraverse
PubMed HealthPhentolamine (Injection)
Drug ClassesAntihypertensive, Diagnostic Agent, Pheochromocytoma, Toxicology-Antidote Agent
Drug LabelPhentolamine mesylate is phenol,3-[[(4,5-dihydro-1 H-imidazol-2-yl)methyl](4-methyl-phenyl)amino]-, methanesulfonate (salt), a non-specific alpha adrenergic blocker.Phentolamine mesylate USP is a white to off-white, odorless crystalline powder with a...
Active IngredientPhentolamine mesylate
Dosage FormInjectable
RouteInjection
Strength0.4mg/1.7ml
Market StatusPrescription
CompanySeptodont Holding

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Adrenergic alpha-Antagonists

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)


Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
alpha-Adrenergic Blocker [EPC]; Adrenergic alpha-Antagonists [MoA]

USDMF

read-more
read-more

01

Antibody Engineering
Not Confirmed

02

Synkem Div Plasto Sa

Germany

USDMF

arrow
Antibody Engineering
Not Confirmed

03

Antibody Engineering
Not Confirmed

03

Antibody Engineering
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-01-10

Pay. Date : 2012-12-21

DMF Number : 16428

Submission : 2003-02-13

Status : Active

Type : II

blank

04

Antibody Engineering
Not Confirmed

05

Antibody Engineering
Not Confirmed

05

Antibody Engineering
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 12260

Submission : 1996-12-11

Status : Active

Type : II

blank

06

Antibody Engineering
Not Confirmed

06

Antibody Engineering
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-10-28

Pay. Date : 2014-06-12

DMF Number : 28193

Submission : 2014-06-16

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

Apicore LLC

India
Antibody Engineering
Not Confirmed
arrow

Apicore LLC

India
arrow
Antibody Engineering
Not Confirmed

Phentolamine Mesylate USP

Date of Issue : 2022-07-15

Valid Till : 2025-07-02

Written Confirmation Number : WC-0110n

Address of the Firm : 252-253, Dhobikuva-391 440, Opp.Jain Irrigation, Padra Jambusar Highway, Tal.Pad...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 42973-389

Start Marketing Date : 2024-04-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : INJECTION, POWDER, FOR SOLUTION (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

02

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 42973-194

Start Marketing Date : 2012-09-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 73212-028

Start Marketing Date : 2023-01-02

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

04

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 63190-0090

Start Marketing Date : 2003-02-13

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 60592-602

Start Marketing Date : 2023-10-16

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

06

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 51927-0176

Start Marketing Date : 2018-09-24

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

07

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 90027-005

Start Marketing Date : 2022-06-22

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

08

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 90027-005

Start Marketing Date : 2021-01-07

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

09

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 82139-0009

Start Marketing Date : 2022-10-26

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

PHENTOLAMINE MESYLATE

NDC Package Code : 59605-2260

Start Marketing Date : 1996-12-11

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

LGM Pharma

U.S.A
arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Phentolamine Mesylate

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

02

arrow
Antibody Engineering
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLaboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.

Flag Netherlands
Digital Content Digital Content

Phentolamine Mesylate

About the Company : Laboratorium Ofichem is a GMP-certified and FDA-approved API manufacturer with state-of-the-art development and production facilities in the Netherlands. We develop and manufacture...

Laboratorium Ofichem is a GMP-certified and FDA-approved API manufacturer with state-of-the-art development and production facilities in the Netherlands. We develop and manufacture small molecule APIs in a cost-effective, robust, and compliant way. We have our own portfolio of generic APIs, but we also operate as a CDMO for a wide range of customers. We are a stable family-owned business and with nearly 50 years of experience we have a long history of regulatory compliance and a strong reputation for reliability and quality.
Ofichem Company Banner

03

CHEMO

Spain
Antibody Engineering
Not Confirmed
arrow

CHEMO

Spain
arrow
Antibody Engineering
Not Confirmed

Phentolamine

About the Company : More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, ...

More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and manufacturing active pharmaceutical ingredients (APIs) in Italy (Industriale Chimica) and in Spain (Quimica Sintetica). In the 90's, CHEMO starts developing and manufacturing high quality and technology finished dosage forms (FDFs).
blank

04

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Phentolamine Mesylate

About the Company : Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in 2000. It is a state-controlled competitive listed company. Its predecessor was Yangzhou Pharmaceutical Factory, which was e...

Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in 2000. It is a state-controlled competitive listed company. Its predecessor was Yangzhou Pharmaceutical Factory, which was established in 1958. It achieved A-share listing in March 2003 with the stock code "600513". After years of reform and development, the company has grown into a national high-tech enterprise integrating R&D, production and sales. It enjoys a high reputation and reputation in the domestic and foreign pharmaceutical manufacturing fields. The company’s main products include urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics etc
blank

05

Antibody Engineering
Not Confirmed
arrow
arrow
Antibody Engineering
Not Confirmed

Phentolamine

About the Company : Shouyuan chemical (one of the leading chemicals supplier in China) specializes in manufacturing, supplying, and custom synsthesis latest chemicals. Our products cover all kinds of ...

Shouyuan chemical (one of the leading chemicals supplier in China) specializes in manufacturing, supplying, and custom synsthesis latest chemicals. Our products cover all kinds of range like pharmaceuticals, agrochemicals, electronic chemicals, surfactants and other specialty chemicals.
blank

06

Viatris

U.S.A
Antibody Engineering
Not Confirmed
arrow

Viatris

U.S.A
arrow
Antibody Engineering
Not Confirmed

Phentolamine

About the Company : In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (N...

In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640716200,"product":"BULK DRUG PHENTOLAMINE MESYLATE USP BATC","address":"BLOCK NO.252-253, VILLAGE DHOBIKUV A,PADRA JAMBUSAR HIGHWAY TAL PADRA","city":"VADODARA,GUJARAT","supplier":"VIATRIS","supplierCountry":"INDIA","foreign_port":"MILAN - MALPENSA","customer":"NERPHARMA","customerCountry":"ITALY","quantity":"0.46","actualQuantity":"0.46","unit":"KGS","unitRateFc":"29000","totalValueFC":"13350.8","currency":"USD","unitRateINR":2189130.4347826084,"date":"29-Dec-2021","totalValueINR":"1007000","totalValueInUsd":"13350.8","indian_port":"BOMBAY AIR","hs_no":"29332990","bill_no":"7099348","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"BLOCK NO.252-253, VILLAGE DHOBIKUV A,PADRA JAMBUSAR HIGHWAY TAL PADRA, VADODARA,GUJARAT","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693938600,"product":"PHENTOLAMINE MESYLATE USP (DETAILS AS PER INV)","address":"PLOT 121 GIDC MAKARPURA INDL.ESTATE","city":"VADODARA","supplier":"VIATRIS","supplierCountry":"INDIA","foreign_port":"LJUBLJANA - BRNIK","customer":"SANDOZ B2B","customerCountry":"SLOVENIA","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"50","totalValueFC":"4951.3","currency":"USD","unitRateINR":4110,"date":"06-Sep-2023","totalValueINR":"411000","totalValueInUsd":"4951.3","indian_port":"Ahmedabad Air","hs_no":"29332990","bill_no":"3735235","productDescription":"API","marketType":"REGULATED MARKET","country":"SLOVENIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"PLOT 121 GIDC MAKARPURA INDL.ESTATE, VADODARA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695321000,"product":"PHENTOLAMINE KETO ANALOG (QTY:25 G, VALUE USD 11795)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIAL ","customerCountry":"UNITED STATES","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"471800","totalValueFC":"11697.6","currency":"USD","unitRateINR":38840000,"date":"22-Sep-2023","totalValueINR":"971000","totalValueInUsd":"11697.6","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"4116185","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,, TURKAPALLY(V),SHAMEERPET, HYDERABAD","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703097000,"product":"PHENTOLAMINE MESYLATE (QTY:1 X 0.4 G, VALUE: USD 20.75) (FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0004","unit":"KGS","unitRateFc":"51875","totalValueFC":"22.3","currency":"USD","unitRateINR":"4638500","date":"21-Dec-2023","totalValueINR":"1855.4","totalValueInUsd":"22.3","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9348880","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD, US 21704, UNITED STATES OF AMERICA United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703097000,"product":"PHENTOLAMINE MESYLATE (QTY:1 X 200 MG, VALUE: USD 265) (FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0002","unit":"KGS","unitRateFc":"1325000","totalValueFC":"284.7","currency":"USD","unitRateINR":"118477350","date":"21-Dec-2023","totalValueINR":"23695.47","totalValueInUsd":"284.7","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9348880","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD, US 21704, UNITED STATES OF AMERICA United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706725800,"product":"PHENTOLAMINE KETO ANALOG (QTY:1 X 0.25 G, VALUE: USD 154.44)(FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00025","unit":"KGS","unitRateFc":"617760","totalValueFC":"171.7","currency":"USD","unitRateINR":"56995400","date":"01-Feb-2024","totalValueINR":"14248.85","totalValueInUsd":"171.7","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9934529","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD, US 21704, UNITED STATES OF AMERICA United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706725800,"product":"PHENTOLAMINE KETO ANALOG (QTY:1 X 0.35 G, VALUE: USD 211.01)(FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00035","unit":"KGS","unitRateFc":"602885.7","totalValueFC":"234.6","currency":"USD","unitRateINR":"55623085.7","date":"01-Feb-2024","totalValueINR":"19468.08","totalValueInUsd":"234.6","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9934529","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD, US 21704, UNITED STATES OF AMERICA United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706725800,"product":"PHENTOLAMINE KETO ANALOG (QTY:1 X 25 MG, VALUE: USD 898) (FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.000025","unit":"KGS","unitRateFc":"35920000","totalValueFC":"998.5","currency":"USD","unitRateINR":"3314030000","date":"01-Feb-2024","totalValueINR":"82850.75","totalValueInUsd":"998.5","indian_port":"Hyderabad Air","hs_no":"29332990","bill_no":"9934529","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD, US 21704, UNITED STATES OF AMERICA United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720117800,"product":"PHENTOLAMINE MESYLATE PH EUR","address":"HOUSE NO. 63 SECTOR 11A,","city":"CHANDIGARH,CHANDIGARH","supplier":"LABORATORIUM OFLCHEM B.V.","supplierCountry":"NETHERLANDS","foreign_port":"AMSTERDAM, SCHIPHOL","customer":"ABRYL LABORATORIES ","customerCountry":"INDIA","quantity":"0.63","actualQuantity":"630","unit":"GMS","unitRateFc":"162","totalValueFC":"103108.7","currency":"USD","unitRateINR":"13680.9","date":"05-Jul-2024","totalValueINR":"8618967","totalValueInUsd":"103108.7","indian_port":"Delhi Air","hs_no":"29332990","bill_no":"4344159","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Pharma Grade","supplierPort":"AMSTERDAM, SCHIPHOL","supplierAddress":"HEEMBADWEG 5 9651 CZTEL APELTHE NETHERLANDS NETHERLANDS","customerAddress":"HOUSE NO. 63 SECTOR 11A,"}]
29-Dec-2021
05-Jul-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Nyxol (phentolamine ophthalmic solution) is an adrenergic receptor antagonist. It is being evaluated for the treatment Presbyopia.


Lead Product(s): Phentolamine Mesylate

Therapeutic Area: Ophthalmology Brand Name: Nyxol

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 05, 2024

blank

01

Antibody Engineering
Not Confirmed
Antibody Engineering
Not Confirmed

Details : Nyxol (phentolamine ophthalmic solution) is an adrenergic receptor antagonist. It is being evaluated for the treatment Presbyopia.

Brand Name : Nyxol

Molecule Type : Small molecule

Upfront Cash : Not Applicable

September 05, 2024

blank

Details:

Nyxol (phentolamine mesylate ophthalmic solution) is an alpha1/2 adrenergic receptor inhibitor being investigated in Phase 3 for decreased visual acuity under low light after keratorefractive surgery.


Lead Product(s): Phentolamine Mesylate

Therapeutic Area: Ophthalmology Brand Name: Nyxol

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 11, 2024

blank

02

Antibody Engineering
Not Confirmed
Antibody Engineering
Not Confirmed

Details : Nyxol (phentolamine mesylate ophthalmic solution) is an alpha1/2 adrenergic receptor inhibitor being investigated in Phase 3 for decreased visual acuity under low light after keratorefractive surgery.

Brand Name : Nyxol

Molecule Type : Small molecule

Upfront Cash : Not Applicable

April 11, 2024

blank

Details:

Ryzumvi (phentolamine mesylate) is an alpha adrenergic blocker indicated for treating pharmacologically-induced mydriasis produced by adrenergic agonists or parasympatholytic agents like tropicamide.


Lead Product(s): Phentolamine Mesylate

Therapeutic Area: Ophthalmology Brand Name: Ryzumvi

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 01, 2024

blank

03

Viatris

U.S.A
arrow
Antibody Engineering
Not Confirmed

Viatris

U.S.A
arrow
Antibody Engineering
Not Confirmed

Details : Ryzumvi (phentolamine mesylate) is an alpha adrenergic blocker indicated for treating pharmacologically-induced mydriasis produced by adrenergic agonists or parasympatholytic agents like tropicamide.

Brand Name : Ryzumvi

Molecule Type : Small molecule

Upfront Cash : Not Applicable

April 01, 2024

blank

Details:

Nyxol (phentolamine ophthalmic solution) is anadrenergic receptor antagonist. It is being evaluated in phase 3 clinical trials for decreased visual acuity under dim (mesopic) light conditions.


Lead Product(s): Phentolamine Mesylate

Therapeutic Area: Ophthalmology Brand Name: Nyxol

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 04, 2024

blank

04

Antibody Engineering
Not Confirmed
Antibody Engineering
Not Confirmed

Details : Nyxol (phentolamine ophthalmic solution) is anadrenergic receptor antagonist. It is being evaluated in phase 3 clinical trials for decreased visual acuity under dim (mesopic) light conditions.

Brand Name : Nyxol

Molecule Type : Small molecule

Upfront Cash : Not Applicable

January 04, 2024

blank

Details:

Ryzumvi (phentolamine ophthalmic solution) 0.75% is a preservative-free ophthalmic solution and a nonselective alpha adrenergic antagonist, which is investigated for Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists.


Lead Product(s): Phentolamine Mesylate

Therapeutic Area: Ophthalmology Brand Name: Ryzumvi

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Viatris

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 27, 2023

blank

05

Antibody Engineering
Not Confirmed
Antibody Engineering
Not Confirmed

Details : Ryzumvi (phentolamine ophthalmic solution) 0.75% is a preservative-free ophthalmic solution and a nonselective alpha adrenergic antagonist, which is investigated for Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists.

Brand Name : Ryzumvi

Molecule Type : Small molecule

Upfront Cash : Not Applicable

September 27, 2023

blank

Details:

Nyxol® is a preservative-free ophthalmic solution containing 0.75% phentolamine (or 1% phentolamine mesylate), a nonselective alpha adrenergic antagonist that inhibits the contraction of smooth muscle of the iris.


Lead Product(s): Phentolamine Mesylate

Therapeutic Area: Ophthalmology Brand Name: Nyxol

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable February 13, 2023

blank

06

Antibody Engineering
Not Confirmed
Antibody Engineering
Not Confirmed

Details : Nyxol® is a preservative-free ophthalmic solution containing 0.75% phentolamine (or 1% phentolamine mesylate), a nonselective alpha adrenergic antagonist that inhibits the contraction of smooth muscle of the iris.

Brand Name : Nyxol

Molecule Type : Small molecule

Upfront Cash : Not Applicable

February 13, 2023

blank

Details:

Nyxol® is a preservative-free ophthalmic solution containing 0.75% phentolamine (or 1% phentolamine mesylate), a nonselective alpha adrenergic antagonist that inhibits the contraction of smooth muscle of the iris.


Lead Product(s): Phentolamine Mesylate,Pilocarpine Hydrochloride

Therapeutic Area: Ophthalmology Brand Name: Nyxol

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 09, 2023

blank

07

Antibody Engineering
Not Confirmed
Antibody Engineering
Not Confirmed

Details : Nyxol® is a preservative-free ophthalmic solution containing 0.75% phentolamine (or 1% phentolamine mesylate), a nonselective alpha adrenergic antagonist that inhibits the contraction of smooth muscle of the iris.

Brand Name : Nyxol

Molecule Type : Small molecule

Upfront Cash : Not Applicable

January 09, 2023

blank

Details:

Nyxol is a proprietary, preservative-free, stable, investigational eye drop formulation of phentolamine mesylate 0.75% designed to uniquely modulate the pupil size by blocking the α1 receptors found only on the iris dilator muscle without affecting the ciliary muscle.


Lead Product(s): Phentolamine Mesylate

Therapeutic Area: Ophthalmology Brand Name: Nyxol

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable December 06, 2022

blank

08

Antibody Engineering
Not Confirmed
Antibody Engineering
Not Confirmed

Details : Nyxol is a proprietary, preservative-free, stable, investigational eye drop formulation of phentolamine mesylate 0.75% designed to uniquely modulate the pupil size by blocking the α1 receptors found only on the iris dilator muscle without affecting the ...

Brand Name : Nyxol

Molecule Type : Small molecule

Upfront Cash : Not Applicable

December 06, 2022

blank

Details:

Under the terms of the license agreement, Famy will fund Nyxol (phentolamine mesylate) development through FDA approvals, that will be managed by Ocuphire, including clinical, manufacturing, and regulatory activities required for FDA approval of all three Nyxol indications.


Lead Product(s): Phentolamine Mesylate

Therapeutic Area: Ophthalmology Brand Name: Nyxol

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: FamyGen Life Sciences

Deal Size: $45.0 million Upfront Cash: $35.0 million

Deal Type: Licensing Agreement November 07, 2022

blank

09

Antibody Engineering
Not Confirmed
Antibody Engineering
Not Confirmed

Details : Under the terms of the license agreement, Famy will fund Nyxol (phentolamine mesylate) development through FDA approvals, that will be managed by Ocuphire, including clinical, manufacturing, and regulatory activities required for FDA approval of all thre...

Brand Name : Nyxol

Molecule Type : Small molecule

Upfront Cash : $35.0 million

November 07, 2022

blank

Details:

Nyxol® is a preservative-free ophthalmic solution containing 0.75% phentolamine (or 1% phentolamine mesylate), a nonselective alpha adrenergic antagonist that inhibits the contraction of smooth muscle of the iris.


Lead Product(s): Phentolamine Mesylate

Therapeutic Area: Ophthalmology Brand Name: Nyxol

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: American Society of Ophthalmic Administrator

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership November 02, 2022

blank

10

Antibody Engineering
Not Confirmed
Antibody Engineering
Not Confirmed

Lead Product(s) : Phentolamine Mesylate

Therapeutic Area : Ophthalmology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : American Society of Ophthalmic Administrator

Deal Size : Undisclosed

Deal Type : Partnership

Details : Nyxol® is a preservative-free ophthalmic solution containing 0.75% phentolamine (or 1% phentolamine mesylate), a nonselective alpha adrenergic antagonist that inhibits the contraction of smooth muscle of the iris.

Brand Name : Nyxol

Molecule Type : Small molecule

Upfront Cash : Undisclosed

November 02, 2022

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Direct Compression

read-more
read-more

Co-Processed Excipients

read-more
read-more

Parenteral

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

API Stability Enhancers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty